Maritza McIntyre, Ph.D.

Maritza McIntyre, Ph.D., is the chief development officer at StrideBio. She has more than 20 years of experience in the development of gene and cell therapies as an FDA reviewer, in several gene therapy start-up companies including RegenxBio and Bamboo Therapeutics, and most recently as an independent consultant. McIntyre is an incoming member of ASGCT’s Commercialization Committee. She previosly served as chair of the Clinical Trials and Regulatory Affairs Committee, which led ASGCT commentary on numerous FDA guidance documents, co-developed the first FDA liaison meeting with the Government Affairs Committee, assisted in the development of various webinars and online educational materials, and represented the Society in standards-setting efforts in the field.


ASGCT 25th Annual Meeting

May 16-19, 2022

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.